Business Development, Contract Manufacturing and Genomics

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Pharmaceutical Technology

JULY 29, 2022

In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs). According to Bumcrot, regRNAs are “RNAs that arise out of the non-coding genome”. Future Possibilities.

RNA

RNA Gene Expression Gene Gene Therapy

Athersys Announces Three Appointments to Board of Directors

The Pharma Data

NOVEMBER 15, 2020

Prior to Celgene, she held leadership roles in marketing, sales and new business development from 2002 to 2011 at Johnson & Johnson. Most recently, she was a senior executive at Celgene Corporation, where she led corporate strategy from 2012 to 2017. Before that, Ms.

Clinical Trials

Clinical Trials Clinical Trials Production Trials

Clinical Research Informer

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Athersys Announces Three Appointments to Board of Directors

Webinars

Stay Connected